Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SH2 domain–containing protein 3C (SH2D3C) is an adaptor protein found in the cytoplasm, characterized by an SH2 (Src homology 2) domain and a guanine nucleotide exchange factor–like domain[3]. It plays key roles in signal transduction processes involved in cell adhesion, migration, tissue organization, and immune response regulation. SH2D3C participates in integrin-mediated cell adhesion through the BCAR1-CRK-RAPGEF1 pathway, promotes cell migration and invasion through the extracellular matrix, and is critical for the development and function of B cells and T lymphocytes, especially those involved in the splenic marginal zone and peripheral tissues[3]. Multiple transcript variants and isoforms are described, with some isoforms specialized for chemokine-induced lymphocyte migration or participating in distinct signaling pathways. To date, SH2D3C is not recognized as a direct therapeutic target, and there are no known drugs or biomarkers directly associated with it[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SH2 domain–containing protein 3C (SH2D3C).